Investors holding Amaroq (AMRQ) learned this week that the Amaroq AMRQ Main Market upgrade has caught the eye of the Mail on Sunday’s Midas column, which named the Greenland gold miner as one of six stocks it believes can turbocharge a portfolio. The endorsement matters, but the company’s own numbers tell a fuller story that any holder or prospective buyer should read alongside it.
From AIM to the Main Market: What the Listing Change Means
Amaroq joined the London Stock Exchange (LSE) Main Market on 31 July 2026, moving up from AIM. Citigroup Global Markets Limited acted as sponsor and financial adviser, with Panmure Liberum and Canaccord Genuity as brokers. Crucially, Morningstar/Alliance News reported that the company was not raising fresh funds or issuing new shares as part of the transfer, so existing shareholders faced no dilution (the reduction in each share’s value when new shares are issued) from the move itself.
Before that, in February 2026, Amaroq had announced its intention to delist from the TSX Venture Exchange in Canada, with that delisting effective from the close of trading on 19 March 2026. The company is now purely a London-listed stock, which removes the complexity of a dual listing for UK private investors.
The Midas column noted that Amaroq shares have risen from 44p to £1.04 since the column first tipped them in 2022. That is more than a doubling over roughly four years, which looks strong on the surface. The question is what the business now looks like at £1.04.
Amaroq AMRQ Main Market: What the Balance Sheet Shows
As at 30 June 2026, Amaroq’s own investor relations page shows total assets of CAD 426,785,071 and shareholders’ equity of CAD 294,550,884. Cash stood at CAD 28,545,651 against total current liabilities of CAD 37,638,520, meaning current liabilities exceed the cash balance. That is not unusual for a mine in build-out, but it is a number worth watching.
The share count is also worth understanding. According to The Globe and Mail, issued share capital stands at 466,316,513 common shares following recent option exercises. That share count has grown partly because of two oversubscribed equity financings in 2024: £45.5 million raised in February 2024 at 74 pence per share (62.7 million shares) and £27.5 million in December 2024 at 86 pence per share (32.0 million shares), raising aggregate gross proceeds of approximately C$127.3 million, per the company’s 2024 Annual Report. Both rounds were oversubscribed, which is a positive signal, but shareholders who held before those raises did see dilution.
Amaroq’s principal asset is a 100% interest in the Nalunaq Gold mine in Southern Greenland. The company also holds assets in the Sava Copper Belt, exploring for copper, nickel, rare earths and other strategic minerals in the same region.
On production, the company is targeting full-year 2026 gold output of 25,000 to 35,000 ounces at Nalunaq, with annual plant throughput targeted at 100,000 tons. Studies are underway to increase processing capacity to 450 tons per day. These figures come via Quartr’s summary of Amaroq earnings disclosures; the specific guidance has not been verified against a primary IR document, so treat them as indicative rather than definitive until confirmed in a company filing.
Where Analysts Stand on AMRQ
Two brokers have published targets on the stock. Canaccord Genuity, one of Amaroq’s own brokers, reiterated a Speculative Buy rating on 13 August 2026 with a price target of GBX 140 (140 pence). Panmure Gordon reiterated a Buy on 19 November 2025 with a target of GBX 125. The consensus sits at GBX 132.50, according to MarketBeat’s analyst tracker. At £1.04 (104 pence), the stock trades below both targets, but the sample of two analysts is thin and one is a house broker, so the targets carry limited independent weight.
It is worth noting that Canaccord Genuity acted as broker on the Main Market move, so its rating is not independent of the company relationship. That does not make the target wrong, but retail investors should factor in the connection.
The Midas endorsement will bring new eyes to AMRQ. The company’s profile on MarketBeat gives a useful starting snapshot for those coming to the stock fresh. The key near-term test is whether Nalunaq hits the lower end of that 25,000-ounce production target for 2026; if it does, the investment case for the Main Market upgrade starts to look well-timed.
